Key:
Paywall site
Results
-
William B. Schultz
Super Lawyers (Washington, DC), House GOP Tries Last-Minute Push for FDA Marketing Change, The Affordable Care Act: Past, Present and Future with William Schultz, Zuckerman Spaeder Nabs Obama's Ex-Top Health Atty, Obama Health Department GC to Return to Zuckerman Spaeder, Obama's FDA Leaves Mark With Last-Minute Policy Blitz, Trump Wants To Cut Regulations By 75 Percent. Former Agency Lawyers Are Skeptical., FDA Leaders Dish On Agency Policies Under Trump, Ex-HHS Officials Bill Schultz and Ladd Wiley Diagnose Federal Health Policy, A Chisel of Lawyers in Virginia; Jenner Bets on Energy; Kasowitz Answers to Congress, Zuckerman Spaeder Announces Return of Former Partner and Obama Administration Official William B. Schultz, The Leaderless FDA, Bolstering the FDA's Drug-Safety Authority, Chapter 11: Generic Drugs: ANDAs, Section 505(b)(2) NDAs, Patents and Exclusivities, A Modest Servant of Law and Life, I Met the President Because of WordPerfect 6.1, How to Improve Drug Safety, Trump’s new FDA commissioner has a huge decision to make, No Right to an Experiment, Maryland’s price-gouging law targets the wrong prescription drugs, The Affordable Care Act: Past, Present and Future, Challenges and Opportunities in the New Legal Environment, Cost Sharing Reductions: Legal and Policy Challenges, Assuring Patient Access: Future Outlook for Patient Assistance Program, Bill Schultz Receives Distinguished FDA Alumni Award, Zuckerman Spaeder Health Care Practice Named Law360 Practice Group of the Year, Experts in Supreme Court Litigation, Dept. Health & Human Services, and Silicon Valley Join NHeLP Board, Generic Drug Initiatives: FDARA, GDUFA II, and Administrative Proposals, 31 Zuckerman Spaeder Attorneys Recognized in 2019 Edition of The Best Lawyers in America; Three Partners Named “Lawyer of the Year”, Hospitals Sue HHS For Slow-Walking 340B Penalties, Zuckerman Spaeder Clients Win Lawsuits to Stop Cuts and End Implementation Delay of Changes to the 340B Drug Pricing Program, Zuckerman Spaeder Clients Win Lawsuits to Stop Cuts and End Delay of Changes to the 340B Drug Pricing Program, Zuckerman Spaeder’s Health Care Work is Again Recognized with a Law360 Practice Group of the Year Award, Don't enact a law that diminishes the incentive for generic companies to challenge patents, HHS publishes 340B drug ceiling prices in concession to hospital lobby, Co-Chair Welcome, FDLI Annual Conference Planning Committee, HHS Must 'Unscramble The Egg' On Billions In Drug Cuts, 2006 National Law Journal 100 Most Influential Lawyers in America, 33 Zuckerman Spaeder Attorneys Recognized in 2020 Edition of The Best Lawyers in America; Three Partners Named “Lawyer of the Year”, MVP: Zuckerman Spaeder's William Schultz, Partners Schultz and Hufford Named 2019 Law360 MVPs, Health Care Group Of The Year: Zuckerman Spaeder, Zuckerman Spaeder Receives Three Law360 Practice Group of the Year Awards for its Work in White Collar, Health Care, and Benefits, Chambers USA 2020 Recognizes 16 Zuckerman Spaeder Attorneys and 3 offices; Top-Ranked in DC for White-Collar Crime & Govt Investigations and Maryland for General Commercial Litigation, National Law Journal Names Zuckerman Spaeder a “D.C. Litigation Department of the Year”, 33 Zuckerman Spaeder Attorneys Recognized in 2021 Edition of The Best Lawyers in America; Three Partners Named “Lawyer of the Year”; Two Associates Recognized as “Ones to Watch”, 2020 Litigation Trailblazers, William Schultz Recognized as a Litigation Trailblazer by National Law Journal, Who should get the COVID vaccine next?, Should We Fast-Track a Vaccine for the Coronavirus?, Emergency Use Authorization: Past, Present, and Future, To Improve Competition In Generic Drug Markets, The FDA Should Discount User Fees For Small Players, Real-World Evidence in Drug Development and the Impact of the Pandemic, Legal Town Hall: Opportunities for Policies Favoring Generic Drugs Under the Biden Administration, Chambers USA Expands Zuckerman Spaeder Rankings to Include 18 Attorneys Across Firm Offices, How an Unproven Alzheimer’s Drug Got Approved, 'Clock is running out.' As COVID-19 cases climb, Biden faces rising pressure to fill top FDA job, 36 Zuckerman Spaeder Attorneys Recognized in 2022 Edition of The Best Lawyers in America; Two Partners Named “Lawyer of the Year”; Three Associates Recognized as “Ones to Watch”, Accelerated Approval Pathway – Addressing Recent Challenges, A New Report Takes an Evidence-Based Approach to Analyzing the BLOCKING Act, Chambers USA Expands Zuckerman Spaeder Rankings to Include 20 Attorneys Across Firm Offices, An Evidence-Based Assessment of the BLOCKING Act, 38 Zuckerman Spaeder Attorneys Recognized in 2023 Edition of The Best Lawyers in America, Including Three “Lawyers of the Year”, Zuckerman Spaeder Win Restores Federal Drug Discount Program Savings, Medicare's 340B Cuts For 2022 Must End Now, Judge Rules, Zuckerman Spaeder's Beltway Office Shows its Pull as Place to Which Attorney Return, AHA urges 8th Circuit to uphold Arkansas law protecting 340B contract pharmacies, The abortion pill rulings are scaring the FDA and drugmakers. Here’s why., Former FDA Commissioners Call for Reversal of Mifepristone Decision, Warn of “Catastrophic” Consequences for Access to Medications, 2023 FDLI Annual Conference: FDA Under Fire: What Recent Cases Mean for FDA Regulation, Chambers USA Again Places Zuckerman Spaeder Attorneys and Practices at the Top of the Charts, 42 Zuckerman Spaeder Attorneys, Including Six “Ones to Watch,” Recognized in 2024 Edition of The Best Lawyers in America, Leading Healthcare Experts Oppose Lawsuit Challenging Medicare’s Drug Price Negotiation Program, Nationally Recognized Healthcare Experts Oppose AstraZeneca’s Drug Price Negotiation Program Lawsuit, Washington Health Law Summit 2023: ADR in Healthcare: What Works and What Doesn't, Courts Have “Uniformly Rejected” Arguments Made in Drug Price Negotiation Program Lawsuit, According to Experts, Hospital Groups Nationwide Slam Online Tracking Restrictions, Hospitals Nationwide Challenge HHS Website Technology Policy, 10th Circ. Backs FDA E-Cigarettes Marketing Denial, Over Two Dozen Zuckerman Spaeder Attorneys Named to the 2023 Capital Pro Bono Honor Roll, Chambers USA Ranks Half of Zuckerman Spaeder Partners in 2024 Edition, Best Lawyers® Recognizes 40 Zuckerman Spaeder Attorneys, Including Three “Lawyers of the Year” and Seven “Ones to Watch”, Health & Community Groups Urge Supreme Court to Overturn Flavored E-Cigarettes Ruling, Public Health Groups Urge Supreme Court Reversal of Ruling that Effectively Nullifies Tobacco Control Act’s Venue Restrictions & “Cripples” Efforts to Protect Kids from E-Cigarettes, FDA battles vaping industry at the Supreme Court, Zuckerman Spaeder Attorneys Named to the 2024 Capital Pro Bono Honor Roll, Zuckerman Spaeder Continues to Grow Its Recognitions in the Latest Chambers USA Guide, Super Lawyers (Washington, DC), Nearly Half of Zuckerman Spaeder Attorneys Receive The Best Lawyers in America® Recognitions, Including Several “Ones to Watch” -
Jason B. Acton
The FCC and AIDS Education: Helping Broadcasters Serve the Public Interest, Over Two Dozen Zuckerman Spaeder Attorneys Named to the 2023 Capital Pro Bono Honor Roll